Sign in
Taking people in United StatesNo phase

Registry collecting information on people with blood clotting and bleeding disorders

Collects health information from people with hemophilia, thrombosis, sickle cell disease, or Glanzmann thrombasthenia.

Key facts

Who runs it
American Thrombosis and Hemostasis Network
Where
Hickory, United StatesSee the site
Trial code
Registry title
ATHNdataset Registry
Status
Recruiting
People taking part
200,000 people, planned
Started
25 Oct 2024
Expected to end
31 Oct 2055
Type of study
Observational
Record updated
21 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The registry is open to people who are checked for, or may have, a blood disorder and who visit an ATHN Affiliate. Any age can join.

Age
Any age
Sex
All sexes
Disease stage
Anyone evaluated for a blood disorder or who may have one

Main reasons for not taking part

  • People who cannot give consent or assent, and have no Legally Authorized Representative to consent for them

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Any participant evaluated for or the potential to have a blood disorder who has an encounter with an ATHN Affiliate
  • Participants of any age
  • Participant is able to provide consent or assent; a Legally Authorized Representative (LAR) may provide consent on a participant's behalf if a participant is unable to provide self-consent

Who cannot take part

  • Any participant unable to provide consent or assent to participate in the ATHNdataset

Where in United States

  • American Thrombosis and Hemostasis NetworkHickory, United StatesContact: Carol Fedor, ND, RNTaking people

About the trial

What the trial wants to find out

The Hemophilia Treatment Center (HTC) where you receive care is working with The American Thrombosis and Hemostasis Network (ATHN) to look at the quality of life of people with blood disorders and problems.

Read full original descriptionShow less

Doctors, scientists, policymakers, and other health care providers need a large amount of information from a lot of people to answer scientific, public health, and policy questions about better ways to treat blood disorders. They will use the information from the ATHNdataset to answer these questions.

The group in the trial

  • Blood Disorders

    The ATHNdataset is a large, robust real-world registry that can be queried to produce curated subsets of data to support clinical care, outcomes analysis, safety monitoring, practice of treatment, advocacy, public health reporting, quality improvement projects, and research initiatives. Initiatives relying on the ATHNdataset may focus on gaining a greater understanding of blood disorders, the complications of these disorders, their social and economic costs, and the effectiveness of treatments. The population includes all individuals diagnosed with or suspected to have a blood disorder. Participants will contribute data gathered during care encounters with an ATHN Affiliate.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
American Thrombosis and Hemostasis Network ATHNdataset Registry
Plain-language title
Registry collecting information on people with blood clotting and bleeding disordersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
21 April 2026